Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Chronic Lymphocytic LeukemiaCLLProgressive Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaRelapsed Chronic Lymphocytic Leukemia
Trial Locations (14)

Unknown

NOT_YET_RECRUITING

CHU d'Amiens, Amiens

NOT_YET_RECRUITING

CHU de Besançon, Besançon

NOT_YET_RECRUITING

Hopital AVICENNE, Bobigny

NOT_YET_RECRUITING

CHU clermont-ferrand, Clermont-Ferrand

NOT_YET_RECRUITING

CHU de Clermont Ferrand, Clermont-Ferrand

NOT_YET_RECRUITING

CHU Grenoble, Grenoble

NOT_YET_RECRUITING

CHRU de Lille, Lille

NOT_YET_RECRUITING

Centre LEON BERARD, Lyon

NOT_YET_RECRUITING

CHU de Montpellier, Montpellier

NOT_YET_RECRUITING

CHU Nancy, Nancy

NOT_YET_RECRUITING

Hopital Pitié Salpetrière, Paris

NOT_YET_RECRUITING

Hopital Haut LEVEQUE, Pessac

RECRUITING

CHU de Reims, Reims

NOT_YET_RECRUITING

IUCT Oncopole, Toulouse

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER